Inclusion of severely immunocompromised patients in studies assessing antibiotic efficacy

E. J. Harder; K. E. Bowen; R. N. Greenberg

doi:10.1093/clind/16.2.341

Inclusion of severely immunocompromised patients in studies assessing antibiotic efficacy

E. J. Harder, K. E. Bowen, R. N. Greenberg

Internal Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	341
Number of pages	1
Journal	Clinical Infectious Diseases
Volume	16
Issue number	2
DOIs	https://doi.org/10.1093/clind/16.2.341
State	Published - Feb 1993

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/clind/16.2.341

Cite this

@article{b007b5b1eae04bba89f06f5a62c507c8,

title = "Inclusion of severely immunocompromised patients in studies assessing antibiotic efficacy",

author = "Harder, \{E. J.\} and Bowen, \{K. E.\} and Greenberg, \{R. N.\}",

year = "1993",

month = feb,

doi = "10.1093/clind/16.2.341",

language = "English",

volume = "16",

pages = "341",

number = "2",

}

TY - JOUR

T1 - Inclusion of severely immunocompromised patients in studies assessing antibiotic efficacy

AU - Harder, E. J.

AU - Bowen, K. E.

AU - Greenberg, R. N.

PY - 1993/2

Y1 - 1993/2

UR - http://www.scopus.com/inward/record.url?scp=0027401158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027401158&partnerID=8YFLogxK

U2 - 10.1093/clind/16.2.341

DO - 10.1093/clind/16.2.341

M3 - Article

C2 - 8443326

AN - SCOPUS:0027401158

SN - 1058-4838

VL - 16

SP - 341

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 2

ER -

Inclusion of severely immunocompromised patients in studies assessing antibiotic efficacy

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this